Long-term efficacy and safety of biosimilar infliximab...

  • Main
  • 2019 / 02
  • Long-term efficacy and safety of biosimilar infliximab...

Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: Open-label extension of the NOR-SWITCH trial

Goll, Guro L., Jørgensen, Kristin K., Sexton, Joe, Olsen, Inge C, Bolstad, Nils, Haavardsholm, Espen A, Lundin, Knut EA, Tveit, Kåre S, Lorentzen, Merete, Berset, Ingrid P, Fevang, Bjørg TS, Kalstad,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Journal of Internal Medicine
DOI:
10.1111/joim.12880
Date:
February, 2019
File:
PDF, 823 KB
2019
Conversion to is in progress
Conversion to is failed